POTENT, ORALLY-ACTIVE CARBOXYLATE REPLACEMENT ANALOGS OF THE ENDOTHELIN RECEPTOR ANTAGONIST L-749,329

被引：0
|
作者：
FITCH, KJ
WALSH, TF
TOUPENCE, RB
WILLIAMS, DL
NOLAN, NA
OBRIEN, JA
PETTIBONE, DJ
KIVLIGHN, SD
KRAUSE, SM
CLAYTON, FC
ZINGARO, GJ
SIEGL, PKS
GREENLEE, WJ
机构：
[1] MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME RES LABS,DEPT EXPLORATORY CHEM,RAHWAY,NJ 07065
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 209卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：162 / MEDI
相关论文
共 50 条
  • [31] Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist
    Yuyama, H
    Sanagi, M
    Koakutsu, A
    Mori, M
    Fujimori, A
    Harada, H
    Sudoh, K
    Miyata, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 478 (01) : 61 - 71
  • [32] Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist
    Wu, CD
    Chan, MF
    Stavros, F
    Raju, B
    Okun, I
    Mong, S
    Keller, KM
    Brock, T
    Kogan, TP
    Dixon, RAF
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) : 1690 - 1697
  • [33] GR159897 AND RELATED ANALOGS AS HIGHLY POTENT, ORALLY-ACTIVE NONPEPTIDE NEUROKININ NK2 RECEPTOR ANTAGONISTS
    COOPER, AWJ
    ADAMS, HS
    BELL, R
    GORE, PM
    MCELROY, AB
    PRITCHARD, JM
    SMITH, PW
    WARD, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (16) : 1951 - 1956
  • [34] RS-39604 - A POTENT, SELECTIVE, ORALLY-ACTIVE AND LONG-LASTING 5-HT4 RECEPTOR ANTAGONIST
    HEGDE, SS
    BONHAUS, DW
    LEUNG, E
    WONG, EHF
    JOHNSON, LG
    CLARK, RD
    FLIPPIN, LA
    EGLEN, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P380 - P380
  • [35] LR-B/057 - A NOVEL ORALLY-ACTIVE AT1 RECEPTOR ANTAGONIST
    RENZETTI, AR
    CUCCHI, P
    GUELFI, M
    SALIMBENI, A
    SUBISSI, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 : P267 - P267
  • [36] BIOLOGICAL CHARACTERISTICS OF THE NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST - S-1762
    JUST, M
    HROPOT, M
    JABLONKA, B
    KONIG, W
    STILZ, HU
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1444 - 1444
  • [37] PHARMACOLOGY OF LR-B/057, A NOVEL ORALLY-ACTIVE AT(1) RECEPTOR ANTAGONIST
    RENZETTI, AR
    CUCCHI, P
    GUELFI, M
    CIRILLO, R
    SALIMBENI, A
    SUBISSI, A
    GIACHETTI, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (03) : 354 - 360
  • [38] Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist
    Nishikibe, M
    Ohta, H
    Okada, M
    Ishikawa, K
    Hayama, T
    Fukuroda, T
    Noguchi, K
    Saito, M
    Kanoh, T
    Ozaki, S
    Kamei, T
    Hara, K
    William, D
    Kivlighn, S
    Krause, S
    Gabel, R
    Zingaro, G
    Nolan, N
    O'Brien, J
    Clayton, F
    Lynch, J
    Pettibone, D
    Siegl, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (03): : 1262 - 1270
  • [39] ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST BMS-182874 SUPPRESSES NEOINTIMAL DEVELOPMENT IN BALLOON-INJURED RAT CAROTID ARTERIES
    FERRER, P
    VALENTINE, M
    JENKINSWEST, T
    WEBER, H
    GOLLER, NL
    DURHAM, SK
    MOLLOY, CJ
    MORELAND, S
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (06) : 908 - 915
  • [40] A POTENT, ORALLY-ACTIVE, BALANCED AFFINITY ANGIOTENSIN-II AT(1) ANTAGONIST AND AT(2) BINDING INHIBITOR
    DELASZLO, SE
    QUAGLIATO, CS
    GREENLEE, WJ
    PATCHETT, AA
    CHANG, RSL
    LOTTI, VJ
    CHEN, TB
    SCHECK, SA
    FAUST, KA
    KIVLIGHN, SS
    SCHORN, TS
    ZINGARO, GJ
    SIEGL, PKS
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (21) : 3207 - 3210
12345